nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
|
Marzinke, Mark A |
|
|
10 |
11 |
p. e703-e712 |
artikel |
2 |
Eliminating HIV in the UK among men who have sex with men
|
Trickey, Adam |
|
|
10 |
11 |
p. e695-e696 |
artikel |
3 |
Ending HIV in Chicago by 2030
|
Nelson, Roxanne |
|
|
10 |
11 |
p. e702 |
artikel |
4 |
Haematopoietic stem-cell transplantation in an HIV endemic area: time to consider donors exposed to or living with HIV
|
Hendricks, Candice Laverne |
|
|
10 |
11 |
p. e742-e749 |
artikel |
5 |
HIV and fungal priority pathogens
|
Sati, Hatim |
|
|
10 |
11 |
p. e750-e754 |
artikel |
6 |
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
|
Loosli, Tom |
|
|
10 |
11 |
p. e733-e741 |
artikel |
7 |
INSTI era resistance: emerging concern or marginal issue?
|
Kantor, Rami |
|
|
10 |
11 |
p. e696-e698 |
artikel |
8 |
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration
|
Rein, Sophia M |
|
|
10 |
11 |
p. e723-e732 |
artikel |
9 |
Optimising oral PrEP while awaiting long-acting cabotegravir
|
McCormack, Sheena |
|
|
10 |
11 |
p. e694-e695 |
artikel |
10 |
Successes and challenges in Thailand's HIV response
|
Barmania, Sima |
|
|
10 |
11 |
p. e699-e700 |
artikel |
11 |
Tangerine Clinic: championing transgender health care
|
Barmania, Sima |
|
|
10 |
11 |
p. e701 |
artikel |
12 |
The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis
|
Cambiano, Valentina |
|
|
10 |
11 |
p. e713-e722 |
artikel |
13 |
Transplant donation without discrimination
|
The Lancet HIV, |
|
|
10 |
11 |
p. e693 |
artikel |